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PERUBAHAN KETELAPAN RINTANG DARAH-OTAK, 
ULTRASTRUKTUR, DAN EKSPRESI PROTEIN DAN GEN DALAM 
MODEL HIPOPERFUSI SEREBRUM TIKUS 
 
ABSTRAK 
 
Hipoperfusi serebrum ialah keadaan di mana terdapat pengurangan aliran darah 
ke otak.  Keadaan ini boleh diperhatikan dalam kalangan pesakit yang menghidapi 
penyakit kardiovaskular, hipertensi dan dalam kalangan penduduk yang semakin tua. 
Hipoperfusi serebral boleh menyebabkan penyakit neurologi yang lebih teruk 
termasuk demensia vaskular, penyakit Alzheimer dan sklerosis berbilang.  Hipoperfusi 
serebrum mengaruh kepada kerosakan rintangan darah-otak (BBB) dan kajian 
terperinci ini telah dilakukan untuk memahami perilaku BBB semasa hipoperfusi 
serebrum.  Dalam kajian ini, model penyumbatan dua pembuluh digunakan untuk 
mimik keadaan hipoperfusi serebrum dalam tikus.  Menggunakan pengesan eksogenus 
yang mempunyai berat molekul berbeza iaitu pewarna biru Evans (69 kDa) sebagai 
penanda kebocoran makromolekul dan natrium fluoresein (376 Da) sebagai penanda 
kebocoran molekul kecil, kebocoran pewarna biru Evans melalui BBB dapat 
diperhatikan pada fasa awal hipoperfusi serebrum iaitu 1 jam selepas surgeri.  Melalui 
penggunaan mikroskopi elektron pancaran, pembentukan vesikel dan fenestrasi dalam 
sel endotelium dan pembengkakan hujung kaki astrosit dapat diperhatikan.  Ini 
menunjukkan kerosakan selular yang membawa kepada kebocoran BBB semasa 
hipoperfusi serebrum.  Dengan menggunakan pendekatan proteomik, perubahan 
dalam ekspresi protein hidratase aconitate, hidratase enoil-CoA, ribonukleoprotein 
nukleus heterogenen D0 dan β-sinuclein yang terlibat dalam metabolisme tenaga dan 
proses selular termasuk pembentukan rangka sitoplasma, metabolisme asid nukleik 
xxiii 
 
dan tekanan retikulum endoplasma diperhatikan, menunjukkan gangguan dalam laluan 
ini yang mungkin menyumbang kepada kegagalan BBB semasa hipoperfusi serebrum.  
Di samping itu, perubahan dalam ekspresi protein caperon dan protein yang terlibat 
dalam laluan untuk pembentukan saluran darah baru termasuk protein kalretikulin dan 
homolog rudimen peningkat mungkin menunjukkan pengaktifan mekanisme 
pertahanan BBB terhadap kerosakan yang diaruhkan oleh hipoperfusi serebrum.  
Dengan menggunakan pendekatan genomik, perubahan dalam ekspresi gen yang 
mengekod untuk protein hidratase aconitate dan homolog rudimen peningkat tidak 
diperhatikan, menunjukkan perubahan pada tahap translasi tidak diperhatikan di 
peringkat transkripsi.  Oleh itu, adalah baik untuk menyasarkan laluan yang telah 
dikenalpasti pada peringkat protein untuk membangunkan strategi terapeutik untuk 
menghalang kegagalan BBB semasa fasa awal hipoperfusi serebrum.  Pada 
keseluruhannya, kajian ini menunjukkan perubahan setempat fungsi BBB dalam 
keadaan hipoperfusi serebral, dan mencadangkan laluan yang berpotensi untuk 
menyumbang kepada perubahan fungsi fisiologi BBB.  Hasil dapatan kajian ini adalah 
bernilai untuk merekabentuk strategi terapeutik berkesan untuk penyakit-penyakit 
neurologikal yang mempunyai prognosis yang sama. 
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CHANGES OF THE BLOOD-BRAIN BARRIER PERMEABILITY, 
ULTRASTRUCTURE, AND PROTEIN AND GENE EXPRESSIONS IN A 
RAT MODEL OF CEREBRAL HYPOPERFUSION 
 
ABSTRACT 
 
Cerebral hypoperfusion is a condition where there is reduced blood flow to the 
brain.  This condition is observed in patients with cardiovascular diseases, 
hypertension and among the aging population.  Cerebral hypoperfusion leads to more 
severe neurological diseases including vascular dementia, Alzheimer’s disease and 
multiple sclerosis.  Cerebral hypoperfusion induces damages to the blood-brain barrier 
(BBB) and this detailed study was carried out to understand the BBB behavior during 
cerebral hypoperfusion.  In this study, two-vessel occlusion (2VO) model was used to 
mimic cerebral hypoperfusion in rats.  Using exogenous tracers of different molecular 
weight i.e. Evans blue dye (69 kDa) as a marker for macromolecule leakage, and 
sodium fluorescein (376 Da) as a marker for small molecule leakage, BBB leakages to 
Evans blue dye was observed during the early phase of cerebral hypoperfusion, 1-day 
post-surgery in the brain regions frontal cortex, posterior cortex and thalamus-
midbrain.  Using transmission electron microscopy, vesicles and formation of 
fenestration in endothelial cells, and swelling of astrocyte end-feet were observed, 
indicating cellular damages leading to BBB leakages during cerebral hypoperfusion.  
Using proteomics approach, decreases in the expression of proteins, including 
aconitate hydratase, enoyl-CoA hydratase, heterogenous nuclear ribonucleoprotein D0 
and β-synuclein, involved in energy metabolism and cellular processes including 
cytoskeleton formation, nucleic acid metabolism and endoplasmic reticulum stress 
were observed, indicating possible disruption in these pathways which could 
xxv 
 
contribute to BBB failure during cerebral hypoperfusion.  Besides that, increases in 
the expression of chaperone protein and proteins that are involved in the pathway for 
new vessel formation including calreticulin and enhancer rudimentary homolog, may 
indicate the activation of BBB defensive mechanisms against damages induced by 
cerebral hypoperfusion.  Using genomics approach, changes in the expression of genes 
coding for the proteins aconitate hydratase and enhancer rudimentary homolog were 
not observed, indicating changes at the translational level is not observed at the 
transcriptional level.  Therefore, it is good to target the identified pathways at the 
protein level to develop therapeutic strategies to intervene BBB damages during the 
early phase of cerebral hypoperfusion.  On the whole, this study demonstrates regional 
alterations of the BBB function in cerebral hypoperfusion, with suggestions of 
pathways which could potentially contribute to the altered BBB physiology.  Findings 
from this study are valuable for designing effective therapeutic strategies for 
neurological diseases which shared common prognosis. 
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CHAPTER ONE 
INTRODUCTION 
1.1     Introduction 
The blood-brain barrier (BBB) is a dynamic structure that regulates entry and exit of 
substances into and out of the brain (Abbott et al., 2006).  It is formed by brain 
microvascular endothelial cells. The BBB together with astrocytes, pericytes and 
basement membrane which are in close association with neurons are collectively 
known as the neurovascular unit (NVU).  The components of the NVU are in constant 
communication via signalling pathways to ensure homeostasis of the brain 
microenvironment is maintained for optimal functioning of the neuron.  The BBB as 
as component of the NVU therefore prevents any damaging changes in the brain by 
tightly regulating the movement of substances between the brain and the circulating 
blood. 
 
Although the BBB is regarded as the brain’s first-line of defence against pathological 
damages, during certain disease state including cerebral hypoperfusion, damages to 
the BBB incurs leading to severe brain pathologies (Obermeier et al., 2013).  Cerebral 
hypoperfusion is characterized as a reduction of blood flow to the brain thus leading 
to disruption in steady, constant supply of oxygen and nutrients to the brain.  As a 
result, a cascade of changes occurs in the brain including white matter lesion and 
neuronal damages which may lead to more severe neurological disorders including 
Alzheimer’s diseases, dementia and multiple sclerosis (Ueno et al., 2002; Garbuzova-
Davis et al., 2007; de la Torre, 2012).   
 
2 
 
To date, data are available to demonstrate openings of the BBB that occurs during 
cerebral hypoperfusion leading to secondary brain damages (Ueno et al., 2002; 
Khallout, 2013; Edrissi et al., 2016).  However, very little is yet known about the 
possible mechanisms that may lead to BBB openings during cerebral hypoperfusion.  
Here, in order to reveal the possible mechanisms that may lead to BBB damages during 
cerebral hypoperfusion, a rat model that mimics the condition of cerebral 
hypoperfusion was adopted to investigate the changes that occur to the BBB during 
cerebral hypoperfusion.  Spatiotemporal profiling the BBB permeability to low and 
high molecular weight tracers, and ultrastructural changes of the BBB were 
investigated to understand the pattern of the BBB damages during cerebral 
hypoperfusion.  Molecular research methods including comparative total protein 
profiling and target gene analysis were carried out to reveal possible mechanisms that 
may lead to BBB damages during cerebral hypoperfusion. Figure 1.1 outlines research 
activities conducted in this study. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Schematic diagram of research activities. 
  The two-vessel occlusion (2VO) rat model was 
used to mimic cerebral hypoperfusion condition  
 
Spatiotemporal profiling of  the BBB permeability 
was investigated to identify opening of the BBB  
BBB ultrastructure analysis was carried 
out to identify BBB component damages  
 
Comparative protein profiling was investigated to 
identify disruption in BBB molecular mechanism 
pathways 
 
Target gene expression was investigated to 
identify possible gene t herapeutic candidate  
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1.2     Research questions 
• Will the BBB opens during cerebral hypoperfusion in a rat model? 
• What is the time and brain regional patterns of the BBB openings in the brain 
during cerebral hypoperfusion in rat model? 
• Will there be morphological changes to the components of the BBB during cerebral 
hypoperfusion in rat model? 
• What are the changes in the expressions of the BBB proteins during cerebral 
hypoperfusion in rat model? 
• Are there any specific gene changes during cerebral hypoperfusion that may play 
a role as a therapeutic target for BBB damages during cerebral hypoperfusion in 
rat model? 
 
1.3     Objectives of the thesis 
• To investigate the spatiotemporal profiling of the BBB permeability during 
cerebral hypoperfusion 
• To investigate ultrastructural changes of the BBB during cerebral hypoperfusion 
• To investigate the changes in the expression of BBB total proteins during cerebral 
hypoperfusion 
• To investigate the changes in expression of specific genes which may serve as a 
therapeutic target during cerebral hypoperfusion 
 
1.4     Hypothesis 
Cerebral hypoperfusion leads to BBB damages and may cause more severe 
neurological disorders such as vascular dementia and Alzheimer’s disease.  During 
cerebral hypoperfusion, opening of the BBB will be observed in specific regions of 
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the brain associated with cognitive functions.  Damages to components of the BBB 
including specialized endothelial cells, astrocytes and pericytes may lead to BBB 
openings during cerebral hypoperfusion.  Protein expression levels in the BBB will be 
affected as results of cerebral hypoperfusion which then affects the regulatory 
pathways leading to BBB damages.  Changes in the protein expressions will be 
reflected at the genes level. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1    The brain barriers in human  
The brain, as the core organ that controls and regulates all bodily functions, requires a 
constant homeostatic microenvironment for its optimal functioning.  Therefore, it is 
important that the entry and exit of substances into and out of the brain are strictly 
regulated.  As for the purpose, there are four barriers in the brain that formed 
boundaries between the periphery and the brain namely the blood-brain barrier, the 
blood-cerebrospinal fluid barrier, the blood-arachnoid barrier and the cerebrospinal 
fluid-brain barrier (Figure 2.1). 
 
2.1.1 Blood-brain barrier 
The blood-brain barrier (BBB) is the barrier that is found at the interface between the 
circulating blood and the brain except at the circumventricular organs including area 
postrema, median eminence, neurohypophysis, pineal gland, subfornical organ and 
lamina terminalis (Ballabh et al., 2004).  The BBB is made up of specialized 
endothelial cells of the cerebral microvessels, in close association with other cells of 
the neurovascular unit (NVU) including astrocytes and pericytes, which together 
formed a dynamic functioning barrier regulating the movement of substances between 
the blood and the brain parenchyma. 
 
  The barrier characteristics of the BBB include the presence of tight junction proteins 
between the adjacent endothelial cells which are more extensive compared to 
endothelial cells in other parts of the body.  The specialized endothelial cells are also 
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characterized to have very little amount of pinocytotic vesicles and fenestrations, 
which further restricts entry of blood-borne substances into the brain parenchyma. 
 
Figure 2.1. The four barriers present in a human brain.  A. The blood-CSF barrier 
is made up of specialized epithelial cells found at the interface between the blood and 
the CSF at the level of choroid plexus epithelium.  B. The blood-brain barrier is made 
up of specialized endothelial cells found at the interface between the blood and the 
brain, formed by cerebral microvessel endothelium.  C. The CSF-brain barrier is made 
up of embryo specific neuroependymal cells found at the interface between the CSF 
and the brain in the ventricles during early developmental stage.  D. The blood-
arachnoid barrier is made up of arachnoid epithelial cells at the interface between the 
CSF in the subarachnoid space and the overlaying layer of dura mater. Figure is 
adapted from Liddelow (2011). 
 
 
 
2.1.2 Blood-cerebrospinal fluid barrier 
The blood-cerebrospinal fluid barrier (BCSFB) is the barrier found at the interface 
between the blood and the cerebrospinal fluid (CSF) at the choroid plexus (Laterra et 
al., 1999).  Specialized epithelial cells lining the choroid plexus have functional t ight 
junction proteins, forming barrier that regulates the exchange of substances between 
the blood and the CSF.  As the cerebral blood vessels at choroid plexus have 
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fenestrations and no tight junctions, choroid plexus is a major site for exchange of 
substances between the CSF and the brain across the BCSFB including ionic solutes, 
hormones and organic acids (Nilsson et al., 1992).  
 
2.1.3 Blood-arachnoid barrier 
The blood-arachnoid barrier (BAB), which is a part of the BCSFB, is the barrier found 
at the interface between the CSF in the subarachnoid space and the overlaying layer of 
dura mater (Yasuda et al., 2013).  The arachnoid epithelial cells are connected by 
characteristic tight junction proteins that regulate the movement of substances between 
the blood and subarachnoid CSF. Despite still poorly studied and understood, some 
studies have shown that the BAB expressed drug transporters and drug-metabolizing 
enzymes, thus could play an important role in the transport of drugs across the BAB, 
then from the CSF into the brain (Yasuda et al., 2013). 
 
2.1.4 Cerebrospinal fluid-brain barrier 
The cerebrospinal fluid-brain barrier (CSFBB) is the barrier found at the interface 
between the CSF and the brain at the ventricles (Saunders et al., 2012).  This barrier is 
shown to be present only in embryo during the developmental stage and not present at 
adult stage.  The neuroependymal cells lining the ventricular wall have characteristics 
of embryo specific junctional proteins or called “strap junctions” that regulate the 
movement of substances between the CSF and the brain parenchyma. As with 
development into the adult stage, these intercellular junctional proteins disappear. The 
CSFBB plays an important role in the development of the fetus as it allows the entry 
of small molecules such as sucrose from the CSF into the brain but it excludes the 
entry of large molecules such as protein (Liddelow, 2011).  
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2.2 The BBB: a neurovascular unit 
The BBB exists at the level of cerebral microvessel endothelium.  If the whole network 
of cerebral microvessels is stretched out in a single file, it will cover a distance of 
approximately 650 kilometers (Begley and Brightman, 2003).  The extensive network 
of cerebral microvessels is important to ensure that the brain is continuously perfused 
optimally to meet the high demand of oxygen and nutrient supply to ensure optimum 
functioning of the brain.  The importance of the BBB is also noted in the context that 
it is estimated that every neuron in the brain has its own capillary and both structures 
are in close association for efficient cross-talk (Zlokovic, 2005).  Therefore, the BBB 
is not a separate entity, but a complex structure in close association with surrounding 
neurons and other brain cells forming a dynamic structure which is collectively known 
as the neurovascular unit (NVU) (Abbott et al., 2006).  Much understanding of the 
structure and components of the BBB was gained in the 1960s through electron 
microscopy studies. The center to the BBB is the specialized endothelial cells which 
are tightly sealed by tight junctions and they are closely supported by associating 
astrocytes and pericytes (Reese and Karnovsky, 1969; Brightman and Reese, 1969).  
The endothelial cells are separated from the neighboring cells by basement membrane 
which is made up of extracellular matrix proteins mainly collagen, fibronectin and 
laminin (Tilling et al., 1998).  The NVU plays an important role in maintaining optimal 
brain functions through efficient active cross-talk involving signaling molecules in 
various pathways including neurogenesis, angiogenesis, inflammation and blood flow 
regulation (Zlokovic et al., 2008).  Figure 2.2 shows the components that come 
together in close association to form the NVU including the endothelial cell, 
astrocytes, pericyte, basement membrane and neuron. 
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Figure 2.2. Schematic diagram of cross section of the BBB.  The BBB is formed by 
cerebral endothelium which is tightly sealed by tight junction proteins.  The 
endothelial cell is surrounded by basement membrane (basal lamina) that separates the 
endothelial cell from the neighboring cells.  The pericyte enclosed the endothelial cell 
and the astrocyte end-feet encapsulate the complex.  The structure is closely associated 
with a neuron.  Figure is adapted from Abbott and Yusof (2010).  
 
2.2.1 Specialized endothelial cells 
Through electron microscopic studies, it is noted that the endothelial cells that formed 
the BBB are significantly different from the peripheral endothelial cells.  The 
endothelial cells of the BBB are tightly sealed together by tight junction proteins 
leaving very little to almost no space for movement of substances across the BBB via 
the intercellular cleft (Laterra et al., 1999).  Generally, molecules that are hydrophilic 
and of size more than 500 Da are excluded by the BBB (Pardridge, 2013).  The 
specialized endothelial cells also have no fenestrations and very little number of 
vesicles, hence no detectable movement of substances across the BBB by pinocytosis 
(Laterra et al., 1999).  Transcellular movement of hydrophilic substances across the 
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endothelial cells is only possible through specialized transporter proteins found on the 
luminal (blood-facing) and abluminal (brain-facing) membranes of the endothelial 
cells.  Transcellular movement of small, lipohilic molecules across the BBB through 
the membrane lipid bilayer is possible to certain extent, as they will be effluxed by 
efflux transporters that are highly expressed at the endothelial cells (Banks, 2009).   
The endothelial cells are identified to have increased number of mitochondria as 
compared to periphery endothelial cells to accommodate for the energy required for 
the strictly regulated active transport of substances across the BBB through the 
transporter proteins (Carvey et al., 2010). 
 
2.2.2 Basement membrane 
Basement membrane, the acellular component of the NVU, is found completely 
surrounding the endothelial cell separating it from the neighboring brain cells. Despite 
relatively less studied compared to the other components of the NVU, the basement 
membrane is found to be important for maintaining the BBB stability, barrier function 
and it is also involved in vessel formation and inflammatory mechanisms (Sorokin, 
2010).  The basement membrane is made up of dense extracellular matrix proteins 
including laminin, collagen type IV, heparan sulfate proteoglycans and nidogens 
(Baeten and Akassoglou, 2011; Larochelle et al., 2011; Yousif et al., 2013).  The 
structure of the basement membrane is formed by polymerization of laminin and 
collagen which is linked by nidogens (Yurchenco and Patton, 2009).  The basement 
membrane is an important intermediate component involved in the cross-talk between 
the endothelial cells and the neighboring cells including astrocytes, pericytes and 
neurons, as signaling molecules and extracellular matrix receptors are found in the 
basement membrane (Sixt et al., 2001; Tilling et al., 2002a ; Baeten and Akassoglou, 
11 
 
2011).  The basement membrane is also found to be involved in inflammatory 
mechanism as it is reported that isoform of laminin α5 impedes the entry of leukocytes 
into the brain parenchyma (Wu et al., 2009).  Therefore, it is important to acknowledge 
the basement membrane as a dynamic non-cellular active component involved in 
maintaining the integrity of the BBB.  Damages to the basement membrane during 
pathological conditions are often observed concurrently with opening of the BBB 
(Rosenberg et al., 1993; Rascher et al., 2002; Hawkins and Davis, 2005).  
 
2.2.3 Astrocytes 
Astrocyte is an important component of the NVU for maintaining the integrity of the 
BBB through its active interaction with the specialized endothelial cells through 
signaling molecules.  Astrocyte, one of the major glial cells in the brain, was first 
visualized in the late 19th century as star-shaped cells using Golgi’s staining method 
under light microscope (Kimelberg and Nedergaard, 2011).  Astrocyte’s name was 
derived from the Latin words “astra” and “cyte” which translate to star and cell 
respectively (Kimelberg and Nedergaard, 2011).  It is interesting to note that astrocyte 
is the most abundant type of cells in the brain as it is estimated that there are five fold 
more astrocytes in the brain in comparison to neurons (Cherniak, 1990; Nedergaard et 
al., 2003; Sofroniew and Vinters, 2010).  In relation to its abundance in the brain, it is 
no surprise that astrocytes are involved in many pathways for maintaining the optimal 
functioning of the brain including synapse development and formation, ion 
homeostasis maintenance, cerebral blood flow regulation and oxidative mechanism 
(Clarke and Barres, 2013; Leis et al., 2005; Jou, 2008; Koehler et al., 2009). 
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Astrocytes formed close contact with endothelial cells of the BBB by projection of 
many fine processes known as “end-feet” onto the microvessel as seen in Figure 2.2. 
(Abbott et al., 2006).  The astrocyte end-feet are seen to completely ensheathed the 
endothelial cell therefore providing a large surface area for active interaction between 
the two cells.  Astrocytes are known to have direct effect on the integrity of the tight 
junction proteins of the endothelial cells.  In vitro studies have shown that the absence 
of astrocytes caused less tight junctional protein expressions and hence leaky BBB, 
and these effects were reversed when astrocytes were re-introduced (Janzer and Raff, 
1987; Bauer and Bauer, 2000; Thomsen et al., 2015). In in vivo studies looking into 
BBB changes during ischemia, multiple sclerosis, Parkinson’s disease and 
Alzheimer’s disease, it has been observed that reactive astrogliosis, abnormal 
increased in number of astrocytes, and glial scarring caused concurrent BBB damages 
(Bush et al., 1999; Nishie et al., 2004; Tian et al., 2005; Takano et al., 2009; Cabezas 
et al., 2014).  These observations suggest that there is a dynamic cross-talk between 
the astrocytes and the endothelial cells through signaling molecules and receptors for 
the maintenance of barrier properties of the BBB.   
 
However to date, there is no clear understanding yet of the signaling mechanism which 
is involved in for induction of barrier properties of the endothelial cells by astrocytes 
and only few candidate molecules and pathways have been suggested loosely to be 
responsible for the interaction between the two cells.  Using in vitro co-culture of 
endothelial cells and astrocytes, it was demonstrated that transforming growth factor-
beta produced by astrocytes regulates the expression of tissue plasminogen activator 
and thrombomodulin in endothelial cells thus influencing the integrity of the tight 
junction proteins (Tran et al., 1999).  Other in vitro studies suggested basic fibroblast 
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growth factor and glial cell line derived neurotrophic factor as the most plausible 
intermediate signaling molecules secreted by astrocytes to be involved in the cross-
talk between astrocytes and endothelial cells (Igarashi et al., 1999; Sobue et al., 1999).  
A study using knockout mouse model have shown bone morphogenetic protein (BMP) 
acting through the BMP type IA receptor in astrocytes to be the responsible signaling 
molecule for the induction of BBB tightness (Araya et al., 2008).  Although these 
studies have suggested possible candidates of signaling molecules involved in the 
cross-talk between endothelial cells and astrocytes, the overall mechanism and 
pathway involved are yet to be elucidated.   
 
2.2.4 Pericytes 
Pericyte, an important component of the NVU, is found embedded in the basement 
membrane thus placed very closely to the endothelial cells.  The role of pericytes in 
maintaining the integrity of the BBB has been controversial as often its role in 
maintaining the BBB is downplayed due to the focus given on astrocytes as the key 
player.  However, in recent years, the importance of the pericytes is much 
acknowledged and the diverse roles played by pericytes have come to light.  Pericyte 
is a prominent nucleated cell with little cytoplasmic content with few processes 
ensheathing the endothelial cell from the abluminal side (brain-facing) (Hirschi and 
D’Amore, 1996).  In terms of vessel coverage, tissues of the CNS including the brain 
have the highest percentage of blood vessels covered by pericytes as compared to 
periphery blood vessels (Zlokovic et al., 2008; Diaz-Flores et al., 2009).  The ratio of 
pericyte to endothelial cell is estimated to be approximately 1:3 (Zlokovic et al., 2008).  
Therefore, it is highly likely that pericytes support endothelial cell functions and it is 
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hypothesized that the communication between the two cell types occurs through 
paracrine signaling (Bergers and Song, 2005).   
 
Pericyte is a multipotent cell as it is capable of differentiating into different types of 
cells following insults and that explains the diverse role played by pericyte in 
maintaining the brain homeostasis (Dore-Duffy, 2008).  Pericytes are shown to control 
the BBB-related gene expression in endothelial cells and absence of pericytes is known 
to cause leaky BBB (Armulik et al., 2010).  The most interesting role of pericyte is its 
involvement in regulating the cerebral blood flow in coordination with endothelial 
cells through signaling molecules.  Similar to cardiac smooth muscle cells, pericytes 
expressed α-smooth muscle actin and myosin, therefore capable of vasoconstriction 
and vasodilation, hence regulating vessel diameter, blood volume and flow (Rucker et 
al., 2000).  Vasoconstriction and vasodilation by pericytes are controlled by the 
binding of vasoactive compound endothelin-1 onto the receptors on pericytes and the 
production of endothelin-1 is regulated by endothelial cells (Rucker et al., 2000).  This 
is a sophisticated example of mechanism where both the endothelial cell and pericyte 
work in coordination to maintain the cerebral blood flow.  Pericyte is also known as 
the “cleaning agent” of the BBB as it possesses phagocytotic properties as they have 
many scavenger receptors capable of displaying scavenging activity (Thomas, 1999).  
Following downfall of the integrity of the BBB and leakage of substances from the 
blood into the brain parenchyma, pericytes are observed to scavenge foreign 
substances by phagocytosis thus removing the unwanted substances from the brain 
parenchyma (Majno et al., 1961; Kristensson and Olsson, 1973; Balabanov et al., 
1996).   
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As they are in close association within the basement membrane, pericytes and 
endothelial cells are known to communicate actively to maintain the integrity of the 
BBB.  One of the most highlighted paracrine signaling between the endothelial cells 
and pericytes is through the platelet derived growth factor beta (PDGF-β) molecule 
and receptors.  Endothelial cells are known to produce PDGF-β which then binds to 
PDGF-β receptors found on pericytes, regulating recruitment and attachment of 
pericytes onto microvessels (Enge et al., 2002; Quaegebeur et al., 2010).  Another 
paracrine signaling pathway shown to take place between the pericytes and the 
endothelial cells is through the angiopoietin molecules and Tie receptor.  Tie receptor 
is expressed by endothelial cells and the signaling molecules Ang-1 and Ang-2 are 
produced by pericytes (Suri et al., 1996).  This signaling pathway controls the 
attachment of pericytes onto endothelial cells, vessel formation and proliferation 
(Bergers and Song, 2005).  It is important to note that most of these signaling pathways 
between pericytes and endothelial cells are demonstrated in in vitro studies and the 
complex signaling pathways involved in in vivo studies is yet to be explored and 
understood clearly.  
 
2.2.5 Interaction between neurons and other components of the NVU 
It is estimated that every neuron has its own capillary and they lie in extreme close 
vicinity with a separation distance of approximately 8 μm (Abbott et al., 2006).  The 
interaction between the components of the NVU including endothelial cells, 
astrocytes, pericytes and neurons is important for the coordination of synaptic activity 
and maintenance of BBB properties.  Neurons and endothelial cells are known to 
interact through negative feedback mechanism in order to keep the brain 
microenvironment at optimal condition. One such cross-talk between endothelial cells 
16 
 
and neurons is demonstrated during disruption in cerebral blood flow. Neural signaling 
to endothelial cells during ischemia insult caused an increase in production of 
vasoactive compounds by the endothelial cells which then in turn activated the 
vasodilation and vasoconstriction responses to regulate the cerebral blood flow (Busse 
and Fleming, 2003; Sokoya et al., 2006).   
 
Besides that, astrocytes are presumed to be a mediator for the cross-talk between the 
neurons and the endothelial cells. Studies have shown that astrocytes expressed various 
receptors for neurotransmitters and neuromodulators that are involved in the signaling 
pathways between neurons and astrocytes (Grosche et al., 1999; Witcher and Ellis, 
2012).  Astrocytes receive neuronal signals from neurons which then affects the ion 
homeostasis in astrocytes thus initiating a wave of release of neuroactive compounds 
(Banerjee and Bhat, 2007).  Astrocytes are also involved in signaling to neurons for 
synaptic strengthening and transmitting mechanisms thus directly influencing neural 
circuit transmission (Kang et al., 1998; Haydon, 2001; Newman, 2003).   
 
Pericyte, another key player of the NVU, is also involved in neurovascular coupling 
mechanism. Although there are still unclear data on the signaling pathways between 
pericytes and neurons, studies have shown that pericytes responded to electrical 
stimulation, ATP and GABA blockers released by neurons (Peppiatt et al., 2006).  
Using knockout mouse model, loss and decrease in the number of cerebral pericytes 
were shown to cause neuronal damages and initiated vascular-mediated 
neurodegeneration (Bell et al., 2010).   
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These highlighted studies have clearly shown that neuronal functions are regulated by 
components of the NVU and vice versa.  This co-dependent existence of the members 
of the dynamic NVU emphasizes the importance of maintaining the integrity of the 
BBB, thus preserving the well-being of the brain. 
 
2.3 Junctional proteins of the BBB 
The BBB tight barrier regulation is due to the presence of tight junction proteins 
between adjacent endothelial cells.  Only the specialized endothelial cells in the CNS 
have an extensive tight junction structure which is missing in other endothelial cells in 
the peripheral system.  Tight junction proteins are the building blocks for BBB barrier 
characteristics and the dynamic structure and function of the junctional proteins are 
modulated by the components of the NVU including pericytes, astrocytes and neurons 
during physiological condition. Tight junction protein disruption is a common 
hallmark observed during neurovascular pathological conditions (Luissint et al., 
2012).   
 
Tight junction proteins sealed adjacent endothelial cells thus ultimately limiting the 
paracellular passage of blood-borne substances into the brain parenchyma.  This then 
creates an absolute separation between the brain parenchyma and the circulating blood.  
The three essential transmembrane proteins that make up the tight junction of the BBB 
include occludin, claudins and junctional adhesion molecules (JAMs).  These 
membrane spanning junctional proteins are then anchored to the cytoskeleton of the 
endothelial cells via the zonula occludens (ZO).  Figure 2.3 shows the systematic 
complex structure of the junctional proteins present at the membrane edge of the 
specialized endothelial cells.  
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Figure 2.3. Tight junction proteins of the BBB. Occludin, claudins and JAMs are 
transmembrane proteins that sealed adjacent endothelial cells thus restricting the free 
passage of blood-borne substances into the brain parenchyma from the blood.  These 
transmembrane proteins are anchored to the cytoskeleton of the endothelial cells via 
ZO thus maintaining the structure of the tight junction complex. The figure is adapted 
from Liu et al. (2012)   
 
2.3.1 Occludin 
Occludin, a tetra-spanning transmembrane protein of molecular mass of 60 kDa was 
the first protein of the tight junction complex to be identified (Furuse et al., 1993).  
Occludin has four membrane spanning domains, three cytoplasmic domains and two 
extracellular domains with the N- terminus and the C-terminus embedded in the 
cytoplasm (Feldman et al., 2005).  Using occludin knockout mouse model, it was 
observed that absence of occludin did not alter  the tight junction complex suggesting 
that occludin is not required for the formation of the tight junction (Saitou et al., 1997; 
Saitou et al., 2000).  It was concluded that loss of occludin can be compensated by the 
presence of the other transmembrane proteins.    
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However, occludin knockout mouse exhibited gross morphological changes including 
chronic inflammation and calcifications around microvessels (Saitou et al., 2000).  
Therefore, occludin function in the tight junction network is rather complex as it is 
involved in regulatory mechanism for maintaining the integrity of the BBB.  Besides 
regulating the sealing of the tight junctions, occludin is also involved in signaling 
pathways of the BBB as the C-terminus can bind various regulatory molecules 
including protein kinases (Nusrat et al., 2000).  It has been hypothesized that occludin 
may be the initial detector of changes in the external environment which then initiates 
regulatory mechanism to maintain the integrity of the tight junction complex during 
pathological insults (Sandoval and Witt, 2008).  
 
2.3.2 Claudins 
Out of the 24 isoforms of claudins identified, six isoforms of claudins are shown to be 
expressed in the brain including claudin-1, -2, -3, -5, -11 and -12 although some of the 
observations are deemed to be debated as some of the antibody detection showed cross 
reactivity (Huber et al., 2001; Sandoval and Witt, 2008; Romanitan et al., 2010; Liu et 
al., 2012; Haseloff et al., 2015).  However, consistently, it has been observed that 
claudin-1, -3, -5 and -12 are expressed in the brain microvessels and they have low 
molecular mass in the range of 20-24 kDa (Liu et al., 2012).  Specifically, claudin-5 is 
expressed abundantly in cerebral microvessels as it is shown that the mRNA level of 
claudin-5 in the brain is 700 times higher compared to that of claudin-1, -3 and -12 
(Daneman et al., 2010). Therefore, claudin-5 is hypothesized to be the key player in 
sealing the tight junction of the BBB. 
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Despite sharing similar four transmembrane domains structure, claudins do not share 
any sequence homology to that of occludin thus distinguishing them into a separate 
junctional protein group (Wolburg and Lippoldt, 2002). Unlike occludin, claudins 
have been identified to be important for the formation and maintenance of the tightness 
of the BBB tight junction as absence of claudins is associated with leaky BBB.  Using 
a mice model deficit of claudin-5 expression, it was observed that the BBB selectively 
allowed the paracellular movement of substances that are less than 10 kDa but not 
most of blood-borne proteins across the BBB into the brain parenchyma, indicating its 
involvement in restricting the paracellular movement of substances across the BBB 
(Nitta et al., 2003).  Loss of claudin-3 has been associated with movement of blood-
borne immune cells from the blood into the brain parenchyma, initiating the damaging 
inflammation process in the brain during pathological conditions (Pfeiffer et al., 2011).  
With these observations, it is widely accepted that claudins are important for restricting 
the paracellular movement of substances from the blood into the brain and the loss of 
claudins results in selective extravasations of certain molecules into the brain. 
 
During neurovascular pathological conditions, loss of claudins is often observed 
concurrently with tight junction opening of the BBB.  In a study examining protein 
expression of human brain tumor microvessels, it was observed that claudin-1 and 
claudin-5 expressions were significantly down-regulated indicating loss of the 
integrity of the BBB (Liebner et al., 2000).  In an animal model of multiple sclerosis, 
selective loss of claudin-3 was observed while the expression of the other isoforms of 
claudins remained unchanged (Wolburg et al., 2003).  It is therefore important to note 
that the breakdown of the BBB during pathological conditions is not an all loss of tight 
junction proteins event but rather selective changes in the junctional protein network.  
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These observations are then rather interesting for further exploration on the mechanism 
of the changes in the protein network of the BBB during neurovascular diseases which 
may provide insight into possible target molecules specific for each neurovascular 
disease that is being scrutinized.  
 
2.3.3 Junctional adhesion molecules 
Junctional adhesion molecules (JAMs), which are of approximately 40 kDa, are 
enriched at the site of tight junctions and they formed the sealing between cell to cell 
contacts (Liu et al., 2012).  JAMs belong to the immunoglobulin superfamily and they 
are not only expressed at endothelial cells but also at blood-borne cells including 
leukocytes and platelets (Bazzoni, 2011).  Thus, besides forming the tight junction 
network, JAMs are also involved in various mechanism including inflammation, 
angiogenesis and vascular injury repair (Bazzoni, 2011).  Three isoforms of JAMs 
including JAM-A, JAM-B and JAM-C or also known as JAM-1, JAM-2 and JAM-3 
respectively have been identified to be expressed in the brain especially JAM-A which 
is predominantly expressed by cerebral endothelial cells (Sandoval and Witt, 2008).  
JAM-A, -B and -C are observed to be important for maintaining the integrity of the 
BBB by interacting with the other protein components of the tight junction network. 
 
JAMs are observed to be involved as intermediate receptors in translating BBB 
pathological changes to external responses through various mechanisms including 
inflammation and angiogenesis, for initiating vascular damage or repair.  JAM-A is 
shown to be involved in formation of the tight junction as expression of JAM-A causes 
less paracellular movement of substances across the BBB (Dejana et al., 2000).  
Another interesting role of JAM-A is its involvement in transmigration of leukocytes 
22 
 
as absence of the expression of JAM-A causes less movement of leukocytes from the 
blood into the brain parenchyma across the BBB (Del Maschio et al., 1999).  Similar 
to JAM-A, JAM-B is needed for the formation of the tight junction network as JAM-
B restricts paracellular movement of substances across the BBB (Wolburg and 
Lippoldt, 2002).  JAM-C is involved in regulating monocyte trafficking across the 
BBB as expression of JAM-C inhibits the movement of monocytes into brain 
parenchyma (Palmeri et al., 2000).  Overall, the JAMs are important for maintaining 
the structure of the BBB by excluding paracellular movement of substances across the 
BBB and they are involved as intermediates in regulating cerebrovascular 
inflammation mechanism. 
 
2.3.4 Zonula occludens 
Zonula occludens (ZOs) belong to the family of membrane-associated guanylate 
kinases (MAGUK).  They are scaffold proteins that anchor the transmembrane proteins 
including occludin, claudins and JAMs to actin cytoskeleton thus maintaining the tight 
junction proteins in place at the tight junction network.  In brain microvessels, three 
isoforms of ZOs have been identified including ZO-1 (220 kDa), -2 (160 kDa) and -3 
(130 kDa) (Bauer et al., 2010), although detection of ZO-3 is yet to be definitely 
confirmed.   
 
ZO-1 is known to bind to occludin and claudins at the N-terminus and to actin 
cytoskeleton at the C-terminus. Therefore, ZO-1 is important for the assembly of both 
occludin and claudins at the tight junction network. Loss of ZO-1 is associated with 
increased permeability of the BBB with dissolution of claudins (Hawkins and Davis, 
2005).  ZO-2, sharing homologues sequences to that of ZO-1, has similar role in 
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anchoring the transmembrane junctional proteins to the cytoskeleton.  The role of ZO-
3 as a nuclear scaffolding protein is yet to be observed.  However, ZO-3 has been 
shown to be involved in signaling mechanism similar to ZO-1 and ZO-2 thus 
suggesting dual-role of ZOs as anchoring structure and signaling molecule at the BBB 
tight junction network (Bauer et al., 2010).  The ZOs has three domains namely SH3 
domain, guanylate cyclase domain and PDZ domain which are involved in signal 
transduction (Wolburg and Lippoldt, 2002).  Signaling and regulatory molecules 
including protein kinases and catenins are associated with these domains, initiating a 
cascade of BBB signaling mechanism in response to pathological changes in the brain 
(Bauer et al., 2010).   
 
2.4 Movement of substances across the BBB 
The entry and exit of substances into and out of the brain is tightly regulated by the 
BBB.  BBB acts as a checkpoint that allows only the crossing of certain substances 
that passes strict criteria while excluding almost most of the blood content from 
crossing the BBB.  As rules of thumb, molecules that are lipophilic, have molecular 
weight of less than 400 Da and have less than eight hydrogen bonds are predicted to 
be able to trespass the BBB (Muehlbacher et al., 2011; Pardridge, 2012).  However, 
this rule of thumb is not always true as studies have shown that almost 98% of small 
drug molecules of molecular size less than 400 Da are not able to gain entry into the 
brain across the BBB (Pardridge, 2005).  Such highly sophisticated regulation is of 
uttermost importance for maintaining the homeostasis of the brain microenvironment 
as any distortion in the balance of the brain fluid may result in rapid deteriorating 
effects on the brain cells.  The movement of substances across the BBB occurs via 
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either the paracellular or the transcellular pathways which are both highly regulated 
by the BBB structure (Figure 2.4). 
 
Figure 2.4. Movement of substances across the BBB.  Molecules can cross the BBB 
either by the paracellular pathway which involves the movement through the junction 
between two endothelial cells (2) or the transcellular pathway which involves the 
movement through the endothelial cells (1). While paracellular movement involves 
only passive diffusion (2), transcellular movement involves passive diffusion (1), 
influx carrier-mediated transport (3), ATP-mediated efflux transport (4), receptor-
mediated transcytosis (5) and adsorptive-mediated transcytosis (6). Figure is adapted 
from Cerna et al. (2016). 
 
2.4.1 Paracellular pathway  
Paracellular movement of substances across the BBB involves the movement through 
the junction between two adjacent endothelial cells.  In physiological condition, there 
is almost no paracellular movement of substances across the BBB (Van Meer et al., 
1986; Pardridge, 2005; Hawkins et al., 2006; Pardridge, 2012).  This is due to the 
presence of highly intricate tight junction network including occludin, claudins and 
JAMs that sealed adjacent endothelial cells.  As a result, it is almost impossible for 
molecules to transverse across the paracellular pathway.  During pathological 
conditions, however, certain factors such as oxidative and inflammatory factors cause 
